Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. - Wikidata - wikimedia - TriplyDB

Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.

Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.

http://www.wikidata.org/entity/Q36936436

about

Rituximab in renal transplantation ABO incompatible renal transplants: Good or bad?Minimally invasive robotic kidney transplantation for obese patients previously denied access to transplantation Leveraging administrative data to monitor rituximab use in 2875 patients at 42 freestanding children's hospitals across the United States.A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation Current progress in ABO-incompatible kidney transplantation Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.Incidence and predictive factors for infectious disease after rituximab therapy in kidney-transplant patients.Biologics in oral medicine: principles of use and practical considerations.Infectious complications of immune modulatory agents.An update on ABO-incompatible kidney transplantation.Combined use of rituximab and plasmapheresis pre-transplant increases post-transplant infections in renal transplant recipients with basiliximab induction therapy.Determination of rituximab dose according to immunologic risk in ABO-incompatible kidney transplantation.Short-term results of ABO-incompatible living donor kidney transplantation: comparison with ABO-compatible grafts.Comparison of clinical outcome between high and low baseline anti-ABO antibody titers in ABO-incompatible kidney transplantation.ABO desensitization affects cellular immunity and infection control after renal transplantation.Nocardiosis presenting as a lung mass in a kidney transplant recipient.Nocardia infections in solid organ transplantation.Long-term outcome of ABO-incompatible living donor kidney transplantation based on antigen-specific desensitization. An observational comparative analysis.Monitoring infection with Epstein-Barr virus among seromismatch adult renal transplant recipients.Rituximab and memory antibody levels after desensitization.Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.Fatal Pneumococcus Sepsis after Treatment of Late Antibody-Mediated Kidney Graft Rejection.Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients

P2860

Q27026434-808F2211-4901-445C-95C7-A1040D29EBA4 Q28236829-D6B1E7FB-45C7-4CA4-8D51-03A7ECB4F3EB Q28286167-77321C68-0C4F-41B4-83EE-77807337E1AB Q30583310-B731DE89-F3DD-4C78-8593-D58C7A426260 Q35649082-5EE2184E-96D6-4C93-B0AF-684ECE426BAF Q35664634-A2430A7C-C4D9-48DB-835A-ACA274A42C4E Q35677259-1A081F07-9000-48DA-A1C7-7FDBABB7FD8A Q36171175-C9AE95CD-82A9-496F-B224-F8F34C8A1C10 Q36740471-7A50A8B3-ACA4-4CF5-A514-8658B0BA6927 Q37572815-A6DB5DAD-E37F-4141-88AF-9A8381FDB718 Q37993932-2B99BD7D-ED5A-4FDA-8CAF-1769E5DC759B Q38144976-A967EF22-4F62-46E6-8E0A-258C9F8F81E8 Q38267202-7AE522A0-C0AE-4639-B309-12FE1C719B39 Q38447182-C234416C-74BE-401C-8D43-FA5BC5589A37 Q38460398-18FD7E90-EC23-48BD-BD5C-0F566DF6DEB4 Q38468859-0685F201-E952-4A89-BDAE-B0630FC845A4 Q38476939-B0CA8AD8-E499-4B62-9A1C-008DFFD54CE8 Q40879749-83FDD4A2-3F15-499C-BA1B-2CB875A46E53 Q41385556-1197182B-C4B2-4C6B-8EF2-C835DD5872ED Q42272338-1855A208-B60E-4003-8D16-793D0368966D Q43064220-7946BD9A-7BA2-4C5D-BCAD-9A566C4D3761 Q45367792-771F4AF3-A16B-4025-A4A6-4EDFE2F4C560 Q51012123-C1078AA8-F746-4180-8E07-BA1A4B4FE515 Q54481297-08C22D59-D1A1-410E-8988-35B488645546 Q55413815-1685D260-3D0F-4D32-8FBF-814EA5FCD16A Q58999579-42283DE0-4121-44C3-BECB-B108E4847CFC

P2860

Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients.

http://www.wikidata.org/entity/Q36936436

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Infectious complications assoc ...... h renal transplant recipients.

@en

type

label

Infectious complications assoc ...... h renal transplant recipients.

@en

prefLabel

Infectious complications assoc ...... h renal transplant recipients.

@en

P1433

Q36936436-C1779357-81E2-4465-BB30-121303FECB84

P1476

Q36936436-CFA5C495-BB55-4C7D-9678-DB1092971CFF

P2093

Q36936436-0773FB39-B176-438B-8112-8A252B4118EB

Q36936436-21FED649-A310-4B33-830E-2F5699F0D2DE

Q36936436-3387945F-FDD4-4BF1-81FF-078A092A8A65

Q36936436-5CF364C8-8D93-4B46-B02D-ADF1472B463F

Q36936436-5F3FD67E-75D6-45DD-A610-96202301FE24

Q36936436-79F0B7DD-7ACB-4564-AF2C-712571AACEEF

Q36936436-BF22DF50-8CEE-4FCA-A9CB-7CAFDA2DAA4E

P2860

Q36936436-374DA909-CFBE-498F-88F4-9D330835659E

Q36936436-43C2F994-0F51-4896-9E9E-DA1CFE8F306F

Q36936436-7DBF504E-7023-40B9-9384-B8FF164CCE14

Q36936436-885A697C-25E8-4A3B-B20E-4A8AA6BFB12C

Q36936436-8A53D0CC-1FAA-4F0B-B834-BA52B77D9104

Q36936436-95F5D02F-E227-473E-8D5A-C4812C35DE20

Q36936436-9E2979E4-E492-4BE1-ABA2-CB79600E9D78

Q36936436-9EA5B64A-2C95-4972-8082-6F87440A791F

Q36936436-D4F5355C-B24C-477B-9830-FCFD523E8AAC

P304

Q36936436-E443B6C4-4928-413A-A78E-7C5E60B519A2

P31

Q36936436-AE564178-58BE-4C44-ACAC-EA9026481B33

P356

Q36936436-D8C46715-B3F9-49A3-B1BC-2FA83C1109B8

P433

Q36936436-E01AC3BC-AA76-499B-99A4-128715D42FAB

P478

Q36936436-8BD2567D-C9B0-4F2E-88BE-C07841779B70

P577

Q36936436-10AA0EEE-5AC3-4D6D-8D5D-EB8684C431CA

P698

Q36936436-DC70573F-36DB-4A3A-B982-7D1C1828F377

P356

J.1399-0012.2007.00700.X

P1433

Clinical Transplantation

P1476

Infectious complications assoc ...... h renal transplant recipients.

@en

P2093

Enrico Benedetti

http://www.w3.org/2001/XMLSchema#string

Howard Sankary

http://www.w3.org/2001/XMLSchema#string

James Thielke

http://www.w3.org/2001/XMLSchema#string

Jose Oberholzer

http://www.w3.org/2001/XMLSchema#string

Nina M Clark

http://www.w3.org/2001/XMLSchema#string

Shellee A Grim

http://www.w3.org/2001/XMLSchema#string

Thuy Pham

http://www.w3.org/2001/XMLSchema#string

P2860

Rituximab: mechanisms and applications.

ABO-incompatible kidney transplantation.

ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.

Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis.

Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab.

Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers.

Successful high-titer immunoglobulin therapy for persistent parvovirus B19 infection in a lymphoma patient treated with rituximab-combined chemotherapy.

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

Overcoming a positive crossmatch in living-donor kidney transplantation.

P304

628-632

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0012.2007.00700.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17845637

http://www.w3.org/2001/XMLSchema#string